How much funding has bioMATTERS raised?

bioMATTERS has raised $8.3M in total funding. Key investors include Inventure, UVC Partners.

Who is the CEO of bioMATTERS?

Dr. Daniel J. Kelly is the CEO of bioMATTERS. The company was founded in 2019.

Where is bioMATTERS located?

bioMATTERS is headquartered in London, UK.

What funding stage is bioMATTERS at?

bioMATTERS is currently at the Active stage.

How many employees does bioMATTERS have?

bioMATTERS has approximately 11-50 employees.

bioMATTERS

Name: AM Companies Database
Creator: AMPulse
License: https://creativecommons.org/licenses/by/4.0/

MaterialsLondon, UKFounded 2019· One of 961 Materials companies tracked by AMPulse

Develops patent-pending bio-digitally crafted biomaterials and products using 3D printing and robotic biofabrication of living organisms (mycelium, algae, bacteria) and waste, enabling sustainable, customizable interior design solutions.

CEO / Founder: Dr. Daniel J. Kelly
Team Size: 11-50
Stage: Active
Total Funding: $8.3M
Latest Round: Seed
Key Investors: Inventure, UVC Partners

Technology & Products

Key Products

MYCO-ALGA tiling system (3D-printed mycelium and algae tiles); MYCO-CLAY vessels and bowls (3D-printed mycelium, clay, and waste composites); Bio-based pigments (bacteria, algae, plant-based); Customized biomaterials for interior design, product design, and textiles

Technological Advantage

Proprietary bio-fabrication workflows integrate 3D printing with robotic seeding of living organisms (e.g., mycelium, algae) into waste-based pastes, achieving 100% biodegradability and natural aesthetics—protected by patent-pending processes.

Differentiation

Value Proposition

Reduces natural resource extraction and consumption by upcycling waste into 100% biodegradable, aesthetically unique materials, cutting environmental impact while enabling high-customization for design applications.

How They Differentiate

Focuses on 3D-printed living biomaterials from waste and microorganisms for interior design, unlike general bioprinting companies (e.g., BICO, 3D Systems) that target medical tissues or ceramics AM firms (e.g., Desktop Metal) using inert materials.

Market & Competition

Target Customers

Interior designers, architects, product designers, textile manufacturers, and sustainable material specifiers seeking biodegradable, custom-designed biomaterials.

Industry Verticals

Interior Design; Architecture; Product Design; Textiles

Competitors

Ecovative Design; Mogu; MycoWorks

Growth & Milestones

Growth Metrics

Awards and events like QEST/Heritage Crafts Awards 2025, Salone del Mobile Milano 2024, and iF DESIGN TREND REPORT 2024 (from new evidence, indicating industry recognition and trade show presence for bioMATTERS).

Major Milestones

Featured in design exhibitions (e.g., Design Museum London, MAAT Museum); Awarded TOCCO TOP 40 PRODUCTS; Covered by major design and 3D printing media (Designboom, 3Dnatives, VoxelMatters)

https://www.biomatters.org

Why this company matters

bioMATTERS occupies a niche at the intersection of additive manufacturing, synthetic biology, and sustainable interior design. Unlike conventional biomaterial companies that grow mycelium into solid panels or leather alternatives, bioMATTERS uses 3D printing to deposit waste-based pastes and then robotically seeds them with living organisms such as mycelium and algae. This bio-digital workflow enables complex geometries and high customization that are difficult to achieve with traditional mold-based mycelium cultivation.

The company's core product line includes the MYCO-ALGA tiling system, which combines 3D-printed mycelium and algae into biodegradable wall and floor tiles, and MYCO-CLAY vessels made from mycelium, clay, and waste composites. bioMATTERS also produces bio-based pigments derived from bacteria, algae, and plants. All materials are designed to be 100% biodegradable, targeting interior designers, architects, and product designers who need sustainable, custom-shaped alternatives to petroleum-based plastics and mined stone.

bioMATTERS has raised €6.5 million from Inventure and UVC Partners. It has partnered with Xaar for print heads used in the MYCO-ALGA system and with Center Rog and the Museum of Architecture Ljubljana for research and exhibition support. The company has been featured at Salone del Mobile Milano and the Design Museum London, signaling growing interest from the architecture and design community.

The main competitive risk is scalability. While Ecovative Design and MycoWorks have industrial-scale mycelium production, bioMATTERS' process relies on living organisms that require controlled growth conditions and longer production cycles. Its patent-pending biotechnology for bio-digital crafting provides some IP protection, but the company must prove it can move from bespoke design pieces to consistent, large-batch manufacturing without compromising biodegradability or aesthetic quality.